Financial News Feed

Stronger Sell Today AKAO ranks #4744 as SELL CANDIDATE. Weaker Sell
Today AKAO ranks #4744 as SELL CANDIDATE.

AKAO stock Achaogen

AKAO stock
Achaogen

Achaogen Inc (AKAO)’s Stochastic Momentum Index is diving lower and has passed the key level of -40, indicating possible oversold territory. The SMI indicator was developed by William Blau ad presen...

Read more

Wall Street brokerages expect Achaogen Inc (NASDAQ:AKAO) to announce earnings of ($0.72) per share for the current quarter, according to Zacks. Four analysts have made estimates for Achaogen’s earni...

Read more

Achaogen Inc. (NASDAQ:AKAO) and Immuron Limited (NASDAQ:IMRN) compete with each other in the Biotechnology sector. We will analyze and compare their analyst...

Read more

Wall Street analysts expect that Achaogen Inc (NASDAQ:AKAO) will announce sales of $3.12 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimat...

Read more

Once the individual investor has done all the fundamental homework and found a few stocks that they think are poised to be future winners, they may want to figure out when to best get into the market....

Read more

Shares of Achaogen Inc (NASDAQ:AKAO) have been given a consensus rating of “Hold” by the thirteen ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two analysts have ...

Read more

The trend-following momentum indicator that illustrates the relationship between two moving averages is called the Moving Average Convergence Divergence. MACD can be found by subtracting the 26-day ex...

Read more

Strongbridge Biopharma plc (NASDAQ:SBBP) and Achaogen Inc. (NASDAQ:AKAO), both competing one another are Biotechnology companies. We will contrast their...

Read more

After a recent look at shares of Achaogen Inc (AKAO), we have seen that the Percentage Price Oscillator Histogram level is under zero. Traders following the indicator may be using the reading to ident...

Read more

Examining shares of Achaogen, Inc. (NASDAQ:AKAO), we can see that the stock has a current beta of 0.85. Checking in on current price action, company shares had recently touched 0.56. From the session ...

Read more

As Biotechnology businesses, Actinium Pharmaceuticals Inc. (NYSEAMERICAN:ATNM) and Achaogen Inc. (NASDAQ:AKAO), are affected by compare. This especially applies to their risk, analyst recommendations,...

Read more

Aravive Inc. (NASDAQ:ARAV) and Achaogen Inc. (NASDAQ:AKAO) compete with each other in the Biotechnology sector. We will analyze and contrast their profitability, analyst recommendations, risk, institu...

Read more

Both Allogene Therapeutics Inc. (NASDAQ:ALLO) and Achaogen Inc. (NASDAQ:AKAO) compete on a level playing field in the Biotechnology industry. We will evaluate...

Read more

Achaogen Inc. (NASDAQ:AKAO) and Dermira Inc. (NASDAQ:DERM) compete against each other in the Biotechnology sector. We will contrast them and contrast their risk, analyst recommendations, profitability...

Read more

Both Achaogen Inc. (NASDAQ:AKAO) and CollPlant Holdings Ltd. (NASDAQ:CLGN) are Biotechnology companies, competing one another. We will compare their...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank